New Tools in Diagnosis and Therapy


In the future, the Identification of the biochemical and molecular factors and related genes linked to the onset and progression of diseases (biomarkers) will guide the choice of therapies and also the segregation of patients who are most likely to benefit from a given therapy. The development of biomarkers for diseases (with a particular focus on cancer and rare diseases) would probably overcome the current limitations in the technologies of genomics and proteomics, and may change the practice of Clinical Medicine, with unforeseen economic consequences.

Area coordinator:

Prof. Ángel Rodríguez de Lera

Organic Chemist.

More info: Organic ChemistryCINBIO


David Posada. More info: Phylogenomics

Florentino Fernández Riverola. More info: Bioinformatics

Ana Gago Martinez. More info: Analytical and Food ChemistryCINBIO

Lines of research:

  • Epigenetic changes in diseases.
  • Synthesis of epigenetic modulators.
  • Pharmacogenomics and pharmacogenetics of diseases.
  • New biosensors.
  • New tools for biomedical applications.
  • Data analysis (genomic/proteomics)



Friday, February 27, 2015
Thanks to the “Biomedical Capacities Support Programme”, interesting international collaborations are being established at the IBI
Friday, December 19, 2014
International experts have gathered in Vigo for the ninth BIOCAPS scientific seminar to share knowledge about new therapeutic targets
Wednesday, December 10, 2014
Experts from Spanish and French research centres will share knowledge about an overexpressed protein in cancers arising from tobacco exposure